サンプル依頼リスト カート
  • English
市場調査レポート
商品コード
1643970

トゥレット症候群治療の世界市場：2033年までの機会と戦略

Tourette Syndrome Treatment Global Market Opportunities And Strategies To 2033

出版日
ページ情報
英文 282 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
トゥレット症候群治療の世界市場：2033年までの機会と戦略
出版日: 2025年01月27日
発行: The Business Research Company
ページ情報: 英文 282 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界のトゥレット症候群治療市場は、2018年に19億4,993万米ドルと評価され、CAGR2.00％以上で2023年に22億3,000万米ドルまで成長しました。

ヘルスケア施設数の成長

病院や専門施設を含むヘルスケア施設数の増加がこれまでのトゥレット症候群治療市場を牽引しました。病院やがん専門クリニックをはじめとするヘルスケア施設の増加により、トゥレット症候群治療のような近代的な医療療法へのアクセスが向上しました。患者が住んでいる地域で医療サービスを受けやすくなったことで、治療のために遠くの医療機関に通う必要性が減少しました。例えば、2020年AHA年次調査（約6,300の病院と400以上の医療システムの包括的データを表す米国病院協会の調査）によると、米国の登録病院数は2018年の6,146から2019年には6,210に増加しました。また、インドの公立・私立病院数は2017年の37,725から2019年には69,000に増加しました。したがって、このようなヘルスケア施設数の増加は、トゥレット症候群治療市場の需要を増加させました。

目次

第1章 エグゼクティブサマリー

  • トゥレット症候群治療-市場の魅力とマクロ経済情勢

第2章 目次

第3章 表一覧

第4章 図一覧

第5章 レポート構成

第6章 市場の特徴

  • 一般的な市場の定義
  • 概要
  • トゥレット症候群治療市場定義とセグメンテーション
  • 治療タイプ別の市場セグメンテーション
    • 抗アドレナリン薬
    • 抗精神病薬
    • 炭酸脱水酵素阻害剤抗けいれん薬
    • その他の治療タイプ
  • 最終用途別の市場セグメンテーション
    • 病院
    • 専門クリニック
    • その他のエンドユーザー
  • 用途別の市場セグメンテーション
    • 子供
    • 成人

第7章 主要な市場動向

  • 革新的な医薬品がトゥレット症候群患者に新たな希望をもたらすことを目指す
  • レット症候群患者に対する新たな治療法の承認

第8章 トゥレット症候群治療市場：マクロ経済シナリオ

  • COVID-19の影響：トゥレット症候群治療市場
  • ウクライナ戦争の影響：トゥレット症候群治療市場
  • 高インフレの影響：トゥレット症候群治療市場

第9章 世界の市場規模と成長

  • 市場規模
  • 市場成長実績、2018-2023
    • 市場促進要因、2018-2023
    • 市場抑制要因、2018-2023
  • 市場成長予測、2023-2028、2033F
    • 市場促進要因、2023-2028
    • 市場抑制要因、2023-2028

第10章 世界のトゥレット症候群治療市場：セグメンテーション

  • 世界のトゥレット症候群治療市場：治療タイプ別、実績と予測, 2018-2023, 2028F, 2033F
  • 世界のトゥレット症候群治療市場：最終用途別、実績と予測, 2018-2023, 2028F, 2033F
  • 世界のトゥレット症候群治療市場：用途別、実績と予測, 2018-2023, 2028F, 2033F

第11章 トゥレット症候群治療市場：地域・国別分析

  • 世界のトゥレット症候群治療市場：地域別、実績と予測, 2018-2023, 2028F, 2033F
  • 世界のトゥレット症候群治療市場：国別、実績と予測, 2018-2023, 2028F, 2033F

第12章 アジア太平洋市場

第13章 西欧市場

第14章 東欧市場

第15章 北米市場

第16章 南米市場

第17章 中東市場

第18章 アフリカ市場

第19章 競合情勢と企業プロファイル

  • 企業プロファイル
  • AbbVie Inc.
  • Viatris Inc
  • Eli Lilly and Company
  • H. Lundbeck AS
  • Bayer AG

第20章 その他の大手企業と革新的企業

  • Neurocrine Biosciences Inc
  • AstraZeneca plc
  • Bristol-Myers Squibb Co.
  • F Hoffmann-La Roche AG
  • Amneal Pharmaceuticals Inc.
  • Novartis International AG
  • Jazz Pharmaceuticals plc
  • Sunovion Pharmaceuticals Inc.
  • Supernus Pharmaceuticals Inc.
  • Otsuka Pharmaceutical Co. Ltd.
  • Eisai Co. Ltd.
  • Mitsubishi Tanabe Pharma Corporation
  • NeuroSigma Inc.

第21章 競合ベンチマーキング

第22章 競合ダッシュボード

第23章 主要な合併と買収

  • Collegium Pharmaceutical Acquired Ironshore Therapeutics
  • Saladax Biomedical Inc Acquired Janssen Pharmaceutica NV

第24章 機会と戦略

  • 2028年の世界のトゥレット症候群治療市場：新たな機会を提供する国
  • 2028年の世界のトゥレット症候群治療市場：新たな機会を提供するセグメント
  • 2028年の世界のトゥレット症候群治療市場：成長戦略
    • 市場動向に基づく戦略
    • 競合の戦略

第25章 トゥレット症候群治療市場：結論と提言

  • 結論
  • 提言
    • 製品
    • 場所
    • 価格
    • プロモーション
    • 人々

第26章 付録

目次
Product Code: o&s1433

Tourette syndrome treatment refers to medical therapies and pharmaceutical interventions designed to manage the symptoms of Tourette Syndrome (TS), a neurological disorder characterized by repetitive, involuntary movements and vocalizations known as tics.

The tourette syndrome treatment market consists of sales, by entities (organizations, sole traders and partnerships), of tourette syndrome treatment products that are tailored to reduce the frequency, intensity and interference of tics on daily life, improving the quality of life for individuals living with TS. Medications used for TS often involve off-label prescriptions that are selected for their efficacy in controlling tic activity or addressing related conditions like attention-deficit/hyperactivity disorder (ADHD) and obsessive-compulsive disorder (OCD), which frequently co-occur with Tourette Syndrome.

The global tourette syndrome treatment market was valued at $1,949.93 million in 2018 which grew till $2,230.0 million in 2023 at a compound annual growth rate (CAGR) of more than 2.00%.

Growth In the Number Of Healthcare Facilities

During the historic period, growth in the number of healthcare facilities including hospitals and specialized facilities drove the tourette syndrome treatment market. The increasing number of healthcare facilities, notably hospitals and specialist cancer clinics, has increased access to modern medical therapies like tourette syndrome treatment. Patients that had better access to healthcare services in their areas, decreased the need to travel to distant medical institutions for treatment. For example, according to the 2020 AHA Annual Survey (a survey of the American Hospital Association representing comprehensive data of nearly 6,300 hospitals and more than 400 health care systems), the number of registered hospitals in the USA increased from 6,146 in 2018 to 6,210 in 2019. Also, the number of public and private hospitals in India increased from 37,725 in 2017 to 69,000 in 2019. Therefore, this growth in the number of healthcare facilities increased the demand for the tourette syndrome treatment market.

New Treatment Approvals For Rett Syndrome Patients

Companies operating in the tourette syndrome treatment market are focusing on new treatment approvals for rett syndrome patients. For instance, in October 2024, Acadia Pharmaceuticals, a US-based biotechnology company, announced that Health Canada has approved DAYBUE (trofinetide) for the treatment of Rett syndrome, marking a significant milestone as the first and only therapy authorized in Canada for this rare neurodevelopmental disorder. This approval is granted to both adult and pediatric patients aged two years and older. Rett syndrome primarily affects females and is characterized by developmental regression after normal early development, with symptoms including loss of communication skills and gait abnormalities. This approval makes DAYBUE, the first and only authorized treatment, filling a major gap for both patients and healthcare providers.

The global tourette syndrome treatment market is concentrated, with large players operating in the market. The top ten competitors in the market made up to 41.2% of the total market in 2023.

Tourette Syndrome Treatment Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global tourette syndrome treatment market as it emerges from the COVID-19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for tourette syndrome treatment? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The tourette syndrome treatment market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider tourette syndrome treatment market; and compares it with other markets.

The report covers the following chapters

  • Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by treatment type, by end-use and by application.
  • Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
  • Macro-Economic Scenario- The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the tourette syndrome treatment market.
  • Global Market Size And Growth- Global historic (2018-2023) and forecast (2023-2028, 2033F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
  • Regional And Country Analysis- Historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison by region and country.
  • Market Segmentation- Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by treatment type, by end-use and by application in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market.
  • Regional Market Size and Growth- Regional market size (2023), historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
  • Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
  • Other Major And Innovative Companies- Details on the company profiles of other major and innovative companies in the market.
  • Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
  • Competitive Dashboard- Briefs on competitive dashboard of major players.
  • Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
  • Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
  • Conclusions And Recommendations- This section includes recommendations for tourette syndrome treatment providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
  • Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

  • 1) By Treatment Type: Antiadrenergic Agents; Antipsychotic Agents; Carbonic Anhydrase Inhibitor Anticonvulsants; Other Treatments
  • 2) By End-Use: Hospitals; Specialty Clinics; Other End-Users
  • 3) By Application: Children; Adult
  • Companies Mentioned: AbbVie Inc.; Viatris Inc.; Eli Lilly and Company; H. Lundbeck AS; Bayer AG
  • Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; UK; Italy; Spain; Russia
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time-series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; tourette syndrome treatment indicators comparison.
  • Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1 Executive Summary

  • 1.1 Tourette Syndrome Treatment - Market Attractiveness And Macro economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

  • 6.1 General Market Definition
  • 6.2 Summary
  • 6.3 Tourette Syndrome Treatment Market Definition And Segmentations
  • 6.4 Market Segmentation By Treatment Type
    • 6.4.1 Antiadrenergic Agents
    • 6.4.2 Antipsychotic Agents
    • 6.4.3 Carbonic Anhydrase Inhibitor Anticonvulsants
    • 6.4.4 Other Treatments
  • 6.5 Market Segmentation By End-Use
    • 6.5.1 Hospitals
    • 6.5.2 Specialty Clinics
    • 6.5.3 Other End-Users
  • 6.6 Market Segmentation By Application
    • 6.6.1 Children
    • 6.6.2 Adult

7 Major Market Trends

  • 7.1 Innovative Drugs Aim To Provide New Hope For Tourette Syndrome Patients
  • 7.2 New Treatment Approvals For Rett Syndrome Patients

8 Tourette Syndrome Treatment Market - Macro Economic Scenario

  • 8.1 COVID-19 Impact On The Tourette Syndrome Treatment Market
  • 8.2 Impact Of The War In Ukraine On The Tourette Syndrome Treatment Market
  • 8.3 Impact Of High Inflation On The Tourette Syndrome Treatment Market

9 Global Market Size and Growth

  • 9.1 Market Size
  • 9.2 Historic Market Growth, 2018 - 2023, Value ($ Million)
    • 9.2.1 Market Drivers 2018 - 2023
    • 9.2.2 Market Restraints 2018 - 2023
  • 9.3 Forecast Market Growth, 2023 - 2028, 2033F Value ($ Million)
    • 9.3.1 Market Drivers 2023 - 2028
    • 9.3.2 Market Restraints 2023 - 2028

10 Global Tourette Syndrome Treatment Market Segmentation

  • 10.1 Global Tourette Syndrome Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.2 Global Tourette Syndrome Treatment Market, Segmentation By End-Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.3 Global Tourette Syndrome Treatment Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

11 Tourette Syndrome Treatment Market, Regional and Country Analysis

  • 11.1 Global Tourette Syndrome Treatment Market, By Region, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 11.2 Global Tourette Syndrome Treatment Market, By Country, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

12 Asia-Pacific Market

  • 12.1 Summary
    • 12.1.1 Market Overview
    • 12.1.2 Region Information
    • 12.1.3 Market Information
    • 12.1.4 Background Information
    • 12.1.5 Government Initiatives
    • 12.1.6 Regulations
    • 12.1.7 Regulatory Bodies
    • 12.1.8 Major Associations
    • 12.1.9 Taxes Levied
    • 12.1.10 Corporate Tax Structure
    • 12.1.11 Investments
    • 12.1.12 Major Companies
  • 12.2 Asia-Pacific Tourette Syndrome Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.3 Asia-Pacific Tourette Syndrome Treatment Market, Segmentation By End-Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.4 Asia-Pacific Tourette Syndrome Treatment Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.5 Asia-Pacific Tourette Syndrome Treatment Market: Country Analysis
  • 12.6 China Market
  • 12.7 Summary
    • 12.7.1 Market Overview
    • 12.7.2 Country Information
    • 12.7.3 Market Information
    • 12.7.4 Background Information
    • 12.7.5 Government Initiatives
    • 12.7.6 Regulations
    • 12.7.7 Regulatory Bodies
    • 12.7.8 Major Associations
    • 12.7.9 Taxes Levied
    • 12.7.10 Corporate Tax Structure
    • 12.7.11 Major Companies
  • 12.8 China Tourette Syndrome Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.9 China Tourette Syndrome Treatment Market, Segmentation By End-Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.10 China Tourette Syndrome Treatment Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.11 India Market
  • 12.12 India Tourette Syndrome Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.13 India Tourette Syndrome Treatment Market, Segmentation By End-Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.14 India Tourette Syndrome Treatment Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.15 Japan Market
  • 12.16 Japan Tourette Syndrome Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.17 Japan Tourette Syndrome Treatment Market, Segmentation By End-Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.18 Japan Tourette Syndrome Treatment Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.19 Australia Market
  • 12.20 Australia Tourette Syndrome Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.21 Australia Tourette Syndrome Treatment Market, Segmentation By End-Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.22 Australia Tourette Syndrome Treatment Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.23 Indonesia Market
  • 12.24 Indonesia Tourette Syndrome Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.25 Indonesia Tourette Syndrome Treatment Market, Segmentation By End-Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.26 Indonesia Tourette Syndrome Treatment Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.27 South Korea Market
  • 12.28 South Korea Tourette Syndrome Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.29 South Korea Tourette Syndrome Treatment Market, Segmentation By End-Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.30 South Korea Tourette Syndrome Treatment Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

13 Western Europe Market

  • 13.1 Summary
    • 13.1.1 Market Overview
    • 13.1.2 Region Information
    • 13.1.3 Market Information
    • 13.1.4 Background Information
    • 13.1.5 Government Initiatives
    • 13.1.6 Regulations
    • 13.1.7 Regulatory Bodies
    • 13.1.8 Major Associations
    • 13.1.9 Taxes Levied
    • 13.1.10 Corporate Tax Structure
    • 13.1.11 Investments
    • 13.1.12 Major Companies
  • 13.20 Western Europe Tourette Syndrome Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.3 Western Europe Tourette Syndrome Treatment Market, Segmentation By End-Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.4 Western Europe Tourette Syndrome Treatment Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.5 Western Europe Tourette Syndrome Treatment Market: Country Analysis
  • 13.6 UK Market
  • 13.7 UK Tourette Syndrome Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.8 UK Tourette Syndrome Treatment Market, Segmentation By End-Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.9 UK Tourette Syndrome Treatment Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.10 Germany Market
  • 13.11 Germany Tourette Syndrome Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.12 Germany Tourette Syndrome Treatment Market, Segmentation By End-Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.13 Germany Tourette Syndrome Treatment Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.14 France Market
  • 13.15 France Tourette Syndrome Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.16 France Tourette Syndrome Treatment Market, Segmentation By End-Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.17 France Tourette Syndrome Treatment Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.18 Italy Market
  • 13.19 Italy Tourette Syndrome Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.20 Italy Tourette Syndrome Treatment Market, Segmentation By End-Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.21 Italy Tourette Syndrome Treatment Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.22 Spain Market
  • 13.23 Spain Tourette Syndrome Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.24 Spain Tourette Syndrome Treatment Market, Segmentation By End-Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.25 Spain Tourette Syndrome Treatment Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

14 Eastern Europe Market

  • 14.1 Summary
    • 14.1.1 Market Overview
    • 14.1.2 Region Information
    • 14.1.3 Market Information
    • 14.1.4 Background Information
    • 14.1.5 150
    • 14.1.6 150
    • 14.1.7 150
    • 14.1.8 150
    • 14.1.4 Government Initiatives
    • 14.1.5 Regulations
    • 14.1.6 Regulatory Bodies
    • 14.1.7 Major Associations
    • 14.1.8 Taxes Levied
    • 14.1.9 Corporate Tax Structure
    • 14.1.10 Investments
    • 14.1.11 Major companies
  • 14.2 Eastern Europe Tourette Syndrome Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.3 Eastern Europe Tourette Syndrome Treatment Market, Segmentation By End-Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.4 Eastern Europe Tourette Syndrome Treatment Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.5 Eastern Europe Tourette Syndrome Treatment Market: Country Analysis
  • 14.6 Russia Market
  • 14.7 Russia Tourette Syndrome Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.8 Russia Tourette Syndrome Treatment Market, Segmentation By End-Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.9 Russia Tourette Syndrome Treatment Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

15 North America Market

  • 15.1 Summary
    • 15.1.1 Market Overview
    • 15.1.2 Region Information
    • 15.1.3 Market Information
    • 15.1.4 Background Information
    • 15.1.5 Government Initiatives
    • 15.1.6 Regulations
    • 15.1.7 Regulatory Bodies
    • 15.1.8 Major Associations
    • 15.1.9 Taxes Levied
    • 15.1.10 Corporate Tax Structure
    • 15.1.11 Investments
    • 15.1.12 Major Companies
  • 15.2 North America Tourette Syndrome Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.3 North America Tourette Syndrome Treatment Market, Segmentation By End-Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.4 North America Tourette Syndrome Treatment Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.5 North America Tourette Syndrome Treatment Market: Country Analysis
  • 15.6 USA Market
  • 15.7 Summary
    • 15.7.1 Market Overview
    • 15.7.2 Country Information
    • 15.7.3 Market Information
    • 15.7.4 Background Information
    • 15.7.5 Government Initiatives
    • 15.7.6 Regulations
    • 15.7.7 Regulatory Bodies
    • 15.7.8 Major Associations
    • 15.7.9 Taxes Levied
    • 15.7.10 Corporate Tax Structure
    • 15.7.11 Investments
    • 15.7.12 Major Companies
  • 15.8 USA Tourette Syndrome Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.9 USA Tourette Syndrome Treatment Market, Segmentation By End-Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.10 USA Tourette Syndrome Treatment Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.11 Canada Market
  • 15.12 Canada Tourette Syndrome Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.13 Canada Tourette Syndrome Treatment Market, Segmentation By End-Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.14 Canada Tourette Syndrome Treatment Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

16 South America Market

  • 16.1 Summary
    • 16.1.1 Market Overview
    • 16.1.2 Region Information
    • 16.1.3 Market Information
    • 16.1.4 Background Information
    • 16.1.5 Government Initiatives
    • 16.1.6 Regulations
    • 16.1.7 Regulatory Bodies
    • 16.1.8 Major Associations
    • 16.1.9 Taxes Levied
    • 16.1.10 Corporate Tax Structure
    • 16.1.11 Investments
    • 16.1.12 Major Companies
  • 16.2 South America Tourette Syndrome Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.3 South America Tourette Syndrome Treatment Market, Segmentation By End-Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.4 South America Tourette Syndrome Treatment Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.5 South America Tourette Syndrome Treatment Market: Country Analysis
  • 16.6 Brazil Market
  • 16.7 Brazil Tourette Syndrome Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.8 Brazil Tourette Syndrome Treatment Market, Segmentation By End-Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.9 Brazil Tourette Syndrome Treatment Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

17 Middle East Market

  • 17.1 Summary
    • 17.1.1 Market Overview
    • 17.1.2 Region Information
    • 17.1.3 Market Information
    • 17.1.4 Background Information
    • 17.1.5 Government Initiatives
    • 17.1.6 Regulations
    • 17.1.7 Regulatory Bodies
    • 17.1.8 Major Associations
    • 17.1.9 Taxes Levied
    • 17.1.10 Corporate Tax Structure
    • 17.1.11 Investments
    • 17.1.12 Major Companies
  • 17.2 Middle East Tourette Syndrome Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 17.3 Middle East Tourette Syndrome Treatment Market, Segmentation By End-Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 17.4 Middle East Tourette Syndrome Treatment Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

18 Africa Market

  • 18.1 Summary
    • 18.1.1 Market Overview
    • 18.1.2 Region Information
    • 18.1.3 Market Information
    • 18.1.4 Background Information
    • 18.1.5 Government Initiatives
    • 18.1.6 Regulations
    • 18.1.7 Regulatory Bodies
    • 18.1.8 Major Associations
    • 18.1.9 Taxes Levied
    • 18.1.10 Corporate Tax Structure
    • 18.1.11 Investments
    • 18.1.12 Major Companies
  • 18.2 Africa Tourette Syndrome Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 18.3 Africa Tourette Syndrome Treatment Market, Segmentation By End-Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 18.4 Africa Tourette Syndrome Treatment Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

19 Competitive Landscape And Company Profiles

  • 19.1 Company Profiles
  • 19.2 AbbVie Inc.
    • 19.2.1 Company Overview
    • 19.2.2 Products And Services
    • 19.2.3 Financial Overview
  • 19.3 Viatris Inc
    • 19.3.1 Company Overview
    • 19.3.2 Products And Services
    • 19.3.3 Financial Overview
  • 19.4 Eli Lilly and Company
    • 19.4.1 Company Overview
    • 19.4.2 Products And Services
    • 19.4.3 Financial Overview
  • 19.5 H. Lundbeck AS
    • 19.5.1 Company Overview
    • 19.5.2 Products And Services
    • 19.5.3 Business Strategy
    • 19.5.4 Financial Overview
  • 19.6 Bayer AG
    • 19.6.1 Company Overview
    • 19.6.2 Products And Services
    • 19.6.3 Financial Overview

20 Other Major And Innovative Companies

  • 20.1 Neurocrine Biosciences Inc
    • 20.1.1 Company Overview
    • 20.1.2 Products and Services
  • 20.2 AstraZeneca plc
    • 20.2.1 Company Overview
    • 20.2.2 Products and Services
  • 20.3 Bristol-Myers Squibb Co.
    • 20.3.1 Company Overview
    • 20.3.2 Products and Services
  • 20.4 F Hoffmann-La Roche AG
    • 20.4.1 Company Overview
    • 20.4.2 Products and Services
  • 20.5 Amneal Pharmaceuticals Inc.
    • 20.5.1 Company Overview
    • 20.5.2 Products and Services
  • 20.6 Novartis International AG
    • 20.6.1 Company Overview
    • 20.6.2 Products and Services
  • 20.7 Jazz Pharmaceuticals plc
    • 20.7.1 Company Overview
    • 20.7.2 Products and Services
  • 20.8 Sunovion Pharmaceuticals Inc.
    • 20.8.1 Company Overview
    • 20.8.2 Products and Services
  • 20.9 Supernus Pharmaceuticals Inc.
    • 20.9.1 Company Overview
    • 20.9.2 Products and Services
  • 20.10 Otsuka Pharmaceutical Co. Ltd.
    • 20.10.1 Company Overview
    • 20.10.2 Products and Services
  • 20.11 Eisai Co. Ltd.
    • 20.11.1 Company Overview
    • 20.11.2 Products and Services
  • 20.12 Mitsubishi Tanabe Pharma Corporation
    • 20.12.1 Company Overview
    • 20.12.2 Products and Services
  • 20.13 NeuroSigma Inc.
    • 20.13.1 Company Overview
    • 20.13.2 Products and Services

21 Competitive Benchmarking

22 Competitive Dashboard

23 Key Mergers And Acquisitions

  • 23.1 Collegium Pharmaceutical Acquired Ironshore Therapeutics
  • 23.2 Saladax Biomedical Inc Acquired Janssen Pharmaceutica NV

24 Opportunities And Strategies

  • 24.1 Global Tourette Syndrome Treatment Market In 2028 - Countries Offering Most New Opportunities
  • 24.2 Global Tourette Syndrome Treatment Market In 2028 - Segments Offering Most New Opportunities
  • 24.3 Global Tourette Syndrome Treatment Market In 2028 - Growth Strategies
    • 24.3.1 Market Trend Based Strategies
    • 24.3.2 Competitor Strategies

25 Tourette Syndrome Treatment Market, Conclusions And Recommendations

  • 25.1 Conclusions
  • 25.2 Recommendations
    • 25.2.1 Product
    • 25.2.2 Place
    • 25.2.3 Price
    • 25.2.4 Promotion
    • 25.2.5 People

26 Appendix

  • 26.1 Geographies Covered
  • 26.2 Market Data Sources
  • 26.3 Research Methodology
  • 26.4 Currencies
  • 26.5 The Business Research Company
  • 26.6 Copyright and Disclaimer